Molecular diagnostics in periprosthetic joint infection.

Authors

Javad Parvizi, Thomas Jefferson University HospitalFollow
Lesley Walinchus, Thomas Jefferson University HospitalFollow
Bahar Adeli, Thomas Jefferson University HospitalFollow

Document Type

Article

Publication Date

11-17-2011

Comments

This article has been peer reviewed. It is the authors' final version prior to publication in International Journal of Artificial Organs

Volume 34, Issue 9, September 2011, Pages 847-855.

The published version is available at DOI: 10.5301/ijao.5000054. Copyright © The International Journal of Artificial Organs

Abstract

Periprosthetic joint infection (PJI) is a significant and costly challenge to the orthopedic community. The lack of a gold standard for diagnosis remains the biggest obstacle in the detection and subsequent treatment of PJI. Molecular markers in the serum and joint fluid aspirate hold immense promise to enhance the development of a firm diagnostic criterion. The primary goal is one marker with high sensitivity and specificity. Here, we review our current research efforts in the field of molecular markers: C-reactive protein, erythrocyte sedimentation rate, white blood cells, and leukocyte esterase. Each marker has been studied to determine its sensitivity, specificity, and positive and negative predictive values in diagnosing PJI.

Recommended Citation

Parvizi, Javad; Walinchus, Lesley; and Adeli, Bahar, "Molecular diagnostics in periprosthetic joint infection." (2011). Department of Orthopaedic Surgery Faculty Papers. Paper 33.
https://jdc.jefferson.edu/orthofp/33

PubMed ID

22094565